Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer. Dube-Pelletier M, Labbe C, Cote J, Pelletier-St-Pierre AA, et al. Oncologist 2023 Jun 26:oyad182. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Dube-Pelletier M, Labbe C, Cote J, Pelletier-St-Pierre AA, et al. Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer. Oncologist 2023 Jun 26:oyad182. doi: 10.1093.
PMID: 37364568